Postherpetic Neuralgia How to Prevent It, How to Treat It STEPHAN A
Total Page:16
File Type:pdf, Size:1020Kb
PEER REVIEWED FEATURE 2 CPD POINTS Postherpetic neuralgia How to prevent it, how to treat it STEPHAN A. SCHUG MD, FANZCA, FPMANZCA AHMAD AFIFI MOHD ARSHAD MB BCh, MMed(Anaesthesiology) Postherpetic neuralgia (PHN) is a common late complication of acute shingles. This neuropathic pain is often severe and accompanied by sensitivity to touch. It significantly impairs the quality of life of affected patients. The difficulties in treating PHN justify preventive measures such as vaccination and early aggressive management of the acute shingles episode. aricella-zoster virus (VZV) is an exclusively human KEY POINTS neurotropic alphaherpesvirus that invokes cellular- mediated immunity in patients who develop the p rimary • Shingles, resulting from reactivation of varicella-zoster virus (VZV; the cause of chickenpox) is a common acute infection varicella (chickenpox). The virus remains Vdormant in the cranial nerve ganglia, dorsal root ganglia and disease, particularly in elderly and immunocompromised patients. autonomic ganglia along the neuraxis for years after the initial • The shingles rash is accompanied with, or may be infection. Reactivation of latent VZV in such infected neural preceded by, acute, often severe pain; the persistence of ganglia produces dematomal skin lesions called herpes zoster or neuropathic pain beyond three months is described as shingles (Figure).1 Such reactivation occurs when cellular immu- postherpetic neuralgia (PHN). nity declines – i.e. with increasing age, with some diseases (e.g. • PHN occurs more often in the elderly and has significant malignancy or HIV infection) or when patients are on certain negative effects on quality of life. treatments such as chemotherapy, immunosuppressants or • Vaccination with attenuated VZV is a preventive strategy corticosteroids.1 Complete resolution of symptoms occurs in reducing incidence of acute shingles and thereby PHN; it two to four weeks in many patients.2 However, some patients is recommended for patients over 60 years and will be funded for patients over 70 years from November 2016. may continue to suffer from prolonged sequelae of shingles • Treatment of PHN should follow established guidelines for neuropathic pain; in view of the localised pain and the typically elderly and frail patients affected, topical lignocaine 5% patch is a specific first-line treatment option. Systemic first-line treatments include pregabalin, • MedicineToday 2016; 17(4): 23-29 gabapentin, tricyclic antidepressants and serotonin- noradrenaline reuptake inhibitors, with tramadol Professor Schug is Chair of Anaesthesiology at The University of Western second-line and conventional opioids third-line options. Australia, and Director of Pain Medicine at Royal Perth Hospital, Perth, WA. Dr Arshad is Pain Specialist and Anaesthesiologist at the Pain Management © JOHN BAVOSI/SPL Clinic, Hospital Sultanah Bahiyah, Malaysia. MedicineToday ❙ APRIL 2016, VOLUME 17, NUMBER 4 23 Downloaded for personal use only. No other uses permitted without permission. © MedicineToday 2016. POSTHERPETIC NEURALGIA continued cases of PHN occur in patients older than most patients have some ‘negative’ 50 years.1 symptoms such as reduced sensation (hypo aesthesia) or even numbness. Burden of disease The neuropathic pain of PHN pro- Chronic neuropathic pain conditions are gressively increases throughout the day perceived as being more severe than other and persists through the night; this varia- types of chronic pain and associated with tion appears unaffected by treatment and greater impairment of health-related qual- may be related to diurnal neurohormonal ity of life, patients’ daily functions and, in and neurophysiological changes.7 particular, sleep. These general findings have been confirmed for PHN specifically.4 Diagnosis The amount of time off work, loss of pro- Neuropathic pain is defined as ‘pain ductivity and presence of associated comor- initiated or caused by a primary lesion or bidities such as anxiety, depression and disease of the somatosensory system’.8 For sleep disorders exacerbate the economic research purposes, pain mapping, quan- burden and psychosocial dysfunctions of titative sensory testing (QST), the capsaicin 5 Figure. Elderly woman with shingles affecting neuropathic pain. response test and skin biopsies have been the trigeminal nerve. used to study the course of illness and Clinical presentation correlation with pain symptoms. QST In more than half of all cases of shingles, identifies mechanical allodynia with the that include, most often, postherpetic herpes zoster-associated pain precedes the use of foam, cotton wool or a soft paint- neuralgia (PHN) and, rarely, neurological rash and vesicular eruption by up to seven brush and thermal allodynia with warmth, disorders including ophthalmoplegia, days. This is often perceived as unilateral, cold and heat pain detection.9 multiple cranial nerve palsy, vasculopathy, dermatomal, spontaneous, burning pain The diagnostic criteria for PHN are: myelopathy, motor deficits (often subtle) and paraesthesia, accompanied by itching • pain persisting or recurring more and various inflammatory disorders of with varying symptom severity in the than three months after the onset of the eye.3 affected dermatome. herpes zoster infection Although shingles itself is a painful Clinically subtle presentations of VZV • a painful dermatomal lesion condition (pain occurs in 80% of affected reactivation with the main symptom of • a preceding herpetic eruption in the patients and is often a prodromal symp- unilateral dermatomal pain without skin same territory, and tom), PHN is often defined as a ‘clinically eruptions are called zoster sine herpete. • pain preceding the eruption by fewer meaningful pain’ persisting more than There are also reports of neurological than seven days. three months after the infection.4 dysfunction without skin lesions or rash. Additionally, neuropathic pain inven- Whereas acute herpes zoster-associated tories such as the painDETECT question- Epidemiology of shingles pain has features of inflammatory and neu- naire that systematically evaluate the and PHN ropathic pain, PHN is a purely neuropathic clinical symptoms of neuropathic pain The overall estimated lifetime risk of pain condition. Three main characteristic described above can be used to screen for shingles is about 30%, with more than features are described by patients with PHN: neuropathic pain.10 Other questionnaires two-thirds of cases occurring in those aged • a constant deep aching or burning that require a short examination such as over 50 years. In Australia, approximately pain commonly perceived over the the Leeds Assessment of Neuropathic 150,000 new cases occur each year (an affected dermatome Symptoms and Signs Scale (LANSS) or the incidence of about 7/1000 people/year), • severe paroxysmal, lancinating pain Douleur Neuro pathique 4 questions (DN4) representing around 0.1% of all GP visits. that shears through the area with can also be used.11 Subsequent episodes of shingles are rare varying interval and duration (occurring in fewer than 5% of individuals) • persistent mechanical and/or cold Risk factors for developing PHN but more likely to occur in patients who allodynia, which is particularly Being aware of the risk factors for devel- are immunocompromised. disturbing to most patients, causing oping severe PHN can be helpful to the Subsequent development of PHN also distress on slight tactile contact GP in stratifying a patient’s symptoms on increases with age, with a reported inci- (clothes, blankets) or even airflow initial presentation and the presence of dence of 18% in those aged 50 years, and (draught).6 these may justify the use of more aggres- over 30% in those aged 80 years; 80% of In addition to such ‘positive’ symptoms, sive treatment to try to prevent PHN. © DR H.C. ROBINSON/SPL 24 MedicineToday ❙ APRIL 2016, VOLUME 17, NUMBER 4 Downloaded for personal use only. No other uses permitted without permission. © MedicineToday 2016. TRAVEL WARNING - TRAVELLERS‘ DIARRHOEA Certain clinical features of acute shingles, Treatment of acute shingles including prodromal pain, severe acute Antiviral agents started within 72 hours pain, severe rash and ophthalmic involve- of rash onset provide accelerated reso- ment, more than double the risk of devel- lution of skin lesions and reduce acute oping PHN.12 Other predictive factors are pain caused by shingles but, regrettably, older age, being immunocompromised, have no preventive effect for PHN.22 Fam- being in a lower income group and not ciclovir or valaciclovir are preferred over receiving antiviral treatments.13 aciclovir, as they confer similar benefits As chronic pain is a biopsychosocial but have a better pharmacokinetic profile phenomenon, it is not surprising that and fewer adverse effects.23,24 greater anxiety and depression, lower life Multimodal oral analgesia should satisfaction and greater disease conviction be used to treat acute shingles pain and are psychological determinants for may therefore be a potential approach to PHN.14,15 preventing PHN; however, the evidence for such an effect is limited.25 Prospective Preventive strategies for PHN studies have indicated that regular use of Vaccination paracetamol and tramadol or oxycodone A vaccine containing approximately is effective.23 Topical lignocaine (in the 14 times more live attenuated VZV than form of patches) and topical aspirin have that in varicella (chickenpox) vaccines has some support for use in treating the pain shown efficacy in reducing